Budget impact analysis of implementing a lung cancer screening in high-risk population in Spain
Bibliographic Data
| ID | 21481807 |
|---|---|
| Authors | Aránzazu Hernández-Yumar (0000-0002-3299-4180, Fundación Canaria de Investigación Sanitaria), Cristina Valcárcel‐Nazco (0000-0003-4833-7967, Fundación Canaria de Investigación Sanitaria, corresponding author), Paula Cantero-Muñoz (Servicio Gallego de Salud), Lidia García‐Pérez (0000-0002-5626-8116, Fundación Canaria de Investigación Sanitaria) |
| Year | 2025 |
| Volume | 39 |
| Pages | 102515 |
| Publication date | 2025-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Gaceta Sanitaria (JOURNAL) |
| Journal identifiers | ISSN: 0213-9111 • E-ISSN: 1578-1283 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.gaceta.2025.102515 |
| PMID | 40639990 |
| OpenAlex | W4412363524 |
| Language | EN |
| Citations received | 1 |
| References cited | 12 |
OBJECTIVE: To analyze the cost of implementing a population-based lung cancer screening program using low-dose radiation computed tomography (CT) in a high-risk population in Spain. METHOD: A budget impact analysis (5 years) was performed from the National Health System' perspective, comparing 16 hypothetical scenarios with screening, based on different age ranges and screening frequencies (annual/biennial), with the current scenario without a lung cancer screening program. Diagnosis, treatment and follow-up costs were considered, as well as the screening costs in the hypothetical scenarios (measured in Euros 2024). From the resident population (50-80 years), the target population and the CT scanners needed to cover the program's demand were calculated. A one-way deterministic sensitivity analysis was performed. RESULTS: The gross budget impact was estimated at €1708.19 million for the current scenario. Among the hypothetical scenarios, it can range from €3737.17 million (biennial screening, 55-65 years) to €10 009.54 million (annual screening, 50-80 years), resulting in a net budget impact of €2028.98-€8301.35 million. By acquiring 100% of the necessary scanners, the investment reached approximately 22% of the annual program's own costs in the first year. The net impact could be reduced to €1858-€7519 million, for 0% acquisition. CONCLUSIONS: Implementing a lung cancer screening program would generate a high cost for the Spanish National Health System, amounting more than one billion Euros compared to the scenario without screening
Cost effectiveness · Cost-effectiveness analysis · Cost–benefit analysis · Environmental health · Euros · Lung cancer · Lung cancer screening · Population · Quality-adjusted life year · Delphi Technique in Research · Lung Cancer Diagnosis and Treatment · Lung Cancer Treatments and Mutations · Medicine · Oncology
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |